| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease | Sarah de Crescenzo | 02/28/19 | San Diego |
| Building Biotechs to Last: A Sneak Peek at the Agenda for Dec. 9 | Luke Timmerman | 11/19/13 | San Francisco |
| How Did Your Biotech Company Get Out of a Jam? Join Us Dec. 9 in SF | Luke Timmerman | 11/13/13 | San Francisco |
| Building Biotechs to Last: See Bonnie Anderson, Dan Bradbury & More | Luke Timmerman | 11/07/13 | Boston |
| Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact | Bruce V. Bigelow | 11/08/11 | San Diego |
| Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News | Bruce V. Bigelow | 07/28/11 | San Diego |
| San Diego’s Fight Against Diabesity: The Photo Gallery | Luke Timmerman | 01/28/11 | San Diego |
| Novartis Acquires Genoptix, Elcelyx Raises $6M, Pfenex Gets Subcontract to Work on Malaria Treatment, & More San Diego Life Sciences News | Bruce V. Bigelow | 01/27/11 | San Diego |
| Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug | Luke Timmerman | 01/21/11 | San Diego |
| J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences News | Bruce V. Bigelow | 01/20/11 | San Diego |
| San Diego’s Quest to Fight the “Diabesity” Epidemic, Coming Jan. 27 | Luke Timmerman | 01/13/11 | San Diego |
| How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on Jan. 27 | Luke Timmerman | 12/27/10 | San Diego |
| San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive? | Luke Timmerman | 12/03/10 | San Diego |
| The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny? | Luke Timmerman | 11/22/10 | San Diego |
| CareFusion Hits Acquisition Trail, Cadence Pharmaceuticals Enlists Manufacturing Expertise, Medsphere Systems Sees Explosion in Bookings, & More San Diego Life Sciences News | Denise Gellene | 04/08/10 | San Diego |
| San Diego Biotech in 2030: A Center for Stem Cells, Genomics, Software, Neuroscience | Luke Timmerman | 04/02/10 | San Diego |
| See You Tonight at San Diego Life Sciences 2030 | Luke Timmerman | 03/31/10 | San Diego |
| The 20-Year Outlook for San Diego Life Sciences: Sold Out? Not Anymore | Luke Timmerman | 03/15/10 | San Diego |
| Amylin, Alkermes Sit in Suspense For FDA Verdict on Once-Weekly Diabetes Drug | Luke Timmerman | 03/10/10 | National |
| The 20-Year Future of San Diego Biotech, Coming March 31 | Luke Timmerman | 03/09/10 | San Diego |
| What Will San Diego’s Biotech Hub Look Like in 20 Years? Xconomy Event Takes Long View | Luke Timmerman | 02/16/10 | San Diego |
| Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug | Luke Timmerman | 01/22/10 | San Diego |
| Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs | Luke Timmerman | 11/02/09 | San Diego |
| Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug | Luke Timmerman | 09/29/09 | San Diego |
| Amylin Cuts 200 Sales Reps, Looks for $45M in Savings Next Year | Bruce V. Bigelow | 05/04/09 | San Diego |
| Departed Amylin Co-Founder Greene Says Company in ‘Perfect Storm,’ But Confident in Management | Bruce V. Bigelow | 04/13/09 | San Diego |
